Eichenfield LF - Search Results

1

The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD™): a clinical outcome measure for the severity of atopic dermatitis.

Simpson EL, Bissonnette R, Paller AS, King B, Silverberg JI, Reich K, Thyssen JP, Doll H, Sun L, DeLozier AM, Nunes FP, Eichenfield LF. Simpson EL, et al. Among authors: eichenfield lf. Br J Dermatol. 2022 Oct;187(4):531-538. doi: 10.1111/bjd.21615. Epub 2022 Aug 21. Br J Dermatol. 2022. PMID: 35442530 Free PMC article.

2

Guidelines of care for neurofibromatosis type 1. American Academy of Dermatology Guidelines/Outcomes Committee.

Eichenfield LF, Levy ML, Paller AS, Riccardi VM. Eichenfield LF, et al. J Am Acad Dermatol. 1997 Oct;37(4):625-30. doi: 10.1016/s0190-9622(97)70182-8. J Am Acad Dermatol. 1997. PMID: 9344204 No abstract available.

3

A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients.

Paller A, Eichenfield LF, Leung DY, Stewart D, Appell M. Paller A, et al. Among authors: eichenfield lf. J Am Acad Dermatol. 2001 Jan;44(1 Suppl):S47-57. doi: 10.1067/mjd.2001.109813. J Am Acad Dermatol. 2001. PMID: 11145795 Clinical Trial.

4

Atopic, contact, and seborrheic dermatitis in adolescents.

Lee DJ, Eichenfield LF. Lee DJ, et al. Among authors: eichenfield lf. Adolesc Med. 2001 Jun;12(2):vi, 269-83. Adolesc Med. 2001. PMID: 11404201 Review.

5

Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents.

Eichenfield LF, Lucky AW, Boguniewicz M, Langley RG, Cherill R, Marshall K, Bush C, Graeber M. Eichenfield LF, et al. J Am Acad Dermatol. 2002 Apr;46(4):495-504. doi: 10.1067/mjd.2002.122187. J Am Acad Dermatol. 2002. PMID: 11907497 Clinical Trial.

6

Pimecrolimus 1% cream (Elidel) for atopic dermatitis.

Bernard LA, Bergman JN, Eichenfield LF. Bernard LA, et al. Among authors: eichenfield lf. Skin Therapy Lett. 2002 Apr;7(4):1-3. Skin Therapy Lett. 2002. PMID: 12097994

7

Topical immunomodulators for atopic dermatitis.

Bernard LA, Eichenfield LF. Bernard LA, et al. Among authors: eichenfield lf. Curr Opin Pediatr. 2002 Aug;14(4):414-8. doi: 10.1097/00008480-200208000-00010. Curr Opin Pediatr. 2002. PMID: 12130904 Review. No abstract available.

8

Fluocinolone acetonide 0.01% in peanut oil: therapy for childhood atopic dermatitis, even in patients who are peanut sensitive.

Paller AS, Nimmagadda S, Schachner L, Mallory SB, Kahn T, Willis I, Eichenfield LF. Paller AS, et al. Among authors: eichenfield lf. J Am Acad Dermatol. 2003 Apr;48(4):569-77. doi: 10.1067/mjd.2003.174. J Am Acad Dermatol. 2003. PMID: 12664021 Clinical Trial.

9

International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies.

Ellis C, Luger T, Abeck D, Allen R, Graham-Brown RA, De Prost Y, Eichenfield LF, Ferrandiz C, Giannetti A, Hanifin J, Koo JY, Leung D, Lynde C, Ring J, Ruiz-Maldonado R, Saurat JH; ICCAD II Faculty. Ellis C, et al. Among authors: eichenfield lf. Br J Dermatol. 2003 May;148 Suppl 63:3-10. doi: 10.1046/j.1365-2133.148.s63.1.x. Br J Dermatol. 2003. PMID: 12694268 Free article. Review. No abstract available.

10

Validation of the Eczema Area and Severity Index for atopic dermatitis in a cohort of 1550 patients from the pimecrolimus cream 1% randomized controlled clinical trials programme.

Barbier N, Paul C, Luger T, Allen R, De Prost Y, Papp K, Eichenfield LF, Cherill R, Hanifin J. Barbier N, et al. Among authors: eichenfield lf. Br J Dermatol. 2004 Jan;150(1):96-102. doi: 10.1111/j.1365-2133.2004.05696.x. Br J Dermatol. 2004. PMID: 14746622 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

414 results

Search Page